These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10516866)
1. Early treatment with verapamil or diltiazem in patients with acute myocardial infarction: safety and possible beneficial effects. Sage PR; Kiosoglous AJ; Wuttke RD; Horowitz JD Cardiovasc Drugs Ther; 1999 Jul; 13(4):309-13. PubMed ID: 10516866 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies. Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432 [TBL] [Abstract][Full Text] [Related]
3. Current status of calcium channel blocking drugs after myocardial infarction. Moss AJ Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237 [TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers and mortality in elderly patients with myocardial infarction. Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174 [TBL] [Abstract][Full Text] [Related]
5. Outcome with calcium channel antagonists after myocardial infarction: a community-based study. J Am Coll Cardiol; ; . PubMed ID: 9426027 [TBL] [Abstract][Full Text] [Related]